{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T20:03:28Z","timestamp":1778443408957,"version":"3.51.4"},"reference-count":30,"publisher":"BMJ","issue":"23","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2013,8,6]]},"published-print":{"date-parts":[[2013,12,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>An elevated level of total plasma homocysteine (tHcy) has been associated with risk of coronary heart disease (CHD). The level of tHcy is affected by lifestyle, in addition to genetic predisposition. The methylene tetrahydrofolate reductase (<jats:italic>MTHFR<\/jats:italic>) 677C&gt;T polymorphism (rs1801133) is among the strongest genetic predictors of tHcy. We examined whether the association between tHcy and CHD is modified by the <jats:italic>MTHFR<\/jats:italic> 677C&gt;T polymorphism.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design and setting<\/jats:title>\n                  <jats:p>Data from two case-control studies of first-time myocardial infarction (MI), Stockholm Heart Epidemiology Programme (SHEEP), and for MI and unstable angina, INTERGENE, were analysed in parallel.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>THcy was determined in a total of 1150 cases and 1753 controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interventions<\/jats:title>\n                  <jats:p>None.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>The outcome comprised first-time MI and unstable angina, subsumed as CHD. Logistic regression was used to investigate the association between tHcy and CHD, and its modification by genotype.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>High tHcy was confirmed to be a risk factor for CHD in both studies. In SHEEP, the association between tHcy and MI was observed in <jats:italic>MTHFR<\/jats:italic> 677 C-homozygotes (OR=1.4, 95% CI 1.2 to 1.6, for a difference by 1 SD of log tHcy) and in heterozygotes (OR=1.3, 95% CI 1.1 to 1.6) but not in T-homozygotes, independent of smoking, physical activity and obesity. An effect modification of similar magnitude was observed but not statistically significant in the smaller INTERGENE study, and confirmed in a meta-analysis of both studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Two Swedish case-control studies showed that the association between elevated tHcy and CHD was confined to carriers of the <jats:italic>MTHFR<\/jats:italic> 677 C-allele, which could have implications for the efficiency of tHcy-lowering treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2013-304460","type":"journal-article","created":{"date-parts":[[2013,9,7]],"date-time":"2013-09-07T21:21:18Z","timestamp":1378588878000},"page":"1761-1765","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C&gt;T polymorphism"],"prefix":"10.1136","volume":"99","author":[{"given":"K","family":"Mehlig","sequence":"first","affiliation":[{"name":"Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Leander","sequence":"additional","affiliation":[{"name":"Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"de Faire","sequence":"additional","affiliation":[{"name":"Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Nyberg","sequence":"additional","affiliation":[{"name":"Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"AstraZeneca R&D, M\u00f6lndal, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Berg","sequence":"additional","affiliation":[{"name":"Department of Food and Nutrition, and Sport Science, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Rosengren","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Bj\u00f6rck","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Blennow","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Tognon","sequence":"additional","affiliation":[{"name":"Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Tor\u00e9n","sequence":"additional","affiliation":[{"name":"Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Strandhagen","sequence":"additional","affiliation":[{"name":"Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Lissner","sequence":"additional","affiliation":[{"name":"Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Thelle","sequence":"additional","affiliation":[{"name":"Department of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,9,7]]},"reference":[{"key":"2025092100241494000_99.23.1761.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199104253241701"},{"key":"2025092100241494000_99.23.1761.2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.49.1.31"},{"key":"2025092100241494000_99.23.1761.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.325.7374.1202"},{"key":"2025092100241494000_99.23.1761.4","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000165142.37711.E7"},{"key":"2025092100241494000_99.23.1761.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2010.02259.x"},{"key":"2025092100241494000_99.23.1761.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3925"},{"key":"2025092100241494000_99.23.1761.7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016473"},{"key":"2025092100241494000_99.23.1761.8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/ajcn\/72.2.315","article-title":"Homocysteine and cardiovascular disease: cause or effect?","volume":"72","author":"Brattstrom","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"2025092100241494000_99.23.1761.9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.4.422"},{"key":"2025092100241494000_99.23.1761.10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ajcn\/72.2.324","article-title":"The controversy over homocysteine and cardiovascular risk","volume":"72","author":"Ueland","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"2025092100241494000_99.23.1761.11","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000112581.96154.EA"},{"key":"2025092100241494000_99.23.1761.12","doi-asserted-by":"publisher","DOI":"10.1038\/ng0595-111"},{"key":"2025092100241494000_99.23.1761.13","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-5-1"},{"key":"2025092100241494000_99.23.1761.14","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1182\/blood.V91.11.4158","article-title":"Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction","volume":"91","author":"Girelli","year":"1998","journal-title":"Blood"},{"key":"2025092100241494000_99.23.1761.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.16.2023"},{"key":"2025092100241494000_99.23.1761.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2005.04.009"},{"key":"2025092100241494000_99.23.1761.17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001177"},{"key":"2025092100241494000_99.23.1761.18","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.111.022384"},{"key":"2025092100241494000_99.23.1761.19","first-page":"17","article-title":"The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease","volume":"59","author":"Kadziela","year":"2003","journal-title":"Kardiol Pol"},{"key":"2025092100241494000_99.23.1761.20","first-page":"330","article-title":"High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C\u2192T genotypes","volume":"17","author":"Lin","year":"2008","journal-title":"Asia Pac J Clin Nutr"},{"key":"2025092100241494000_99.23.1761.21","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.1999.00554.x"},{"key":"2025092100241494000_99.23.1761.22","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/clinchem\/45.9.1517","article-title":"Method for the determination of total homocysteine in plasma and urine by stable isotope dilution and electrospray tandem mass spectrometry","volume":"45","author":"Magera","year":"1999","journal-title":"Clin Chem"},{"key":"2025092100241494000_99.23.1761.23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejhg.5200767"},{"key":"2025092100241494000_99.23.1761.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2010.04.017"},{"key":"2025092100241494000_99.23.1761.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.10.011"},{"key":"2025092100241494000_99.23.1761.26","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9427-7"},{"key":"2025092100241494000_99.23.1761.27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1536867X0800800102","article-title":"metan: fixed- and random-effects meta-analysis","volume":"8","author":"Harris","year":"2008","journal-title":"Stata J"},{"key":"2025092100241494000_99.23.1761.28","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/oxfordjournals.aje.a117193","article-title":"Minimum sample size estimation to detect gene-environment interaction in case-control designs","volume":"140","author":"Hwang","year":"1994","journal-title":"Am J Epidemiol"},{"key":"2025092100241494000_99.23.1761.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(01)00560-6"},{"key":"2025092100241494000_99.23.1761.30","first-page":"811","article-title":"The methylenetetrahydrofolate reductase C677T polymorphism is a major determinant of coffee-induced increase of plasma homocysteine: a randomized placebo controlled study","volume":"13","author":"Strandhagen","year":"2004","journal-title":"Int J Mol Med"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2013-304460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:24:23Z","timestamp":1758439463000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2013-304460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,7]]},"references-count":30,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2013,11,5]]},"published-print":{"date-parts":[[2013,12,1]]}},"alternative-id":["10.1136\/heartjnl-2013-304460"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2013-304460","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,7]]}}}